Show Notes
N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
We spoke with Nigel today and asked about the progress the company is making and shareholders question.
N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programs, N4 Pharma will seek to receive upfront payments, milestone payments and ultimately royalty payments once products reach the market.
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
Listen On
Also Listen
-
Zak Mir talks to Fulcrum Metals CEO on reprocessing strategy and TR1 activity
In this interview, Zak Mir speaks with Fulcrum Metals CEO Ryan Mee about the com -
Zak Mir in conversation with Howard White, Chairman of Hydrogen Utopia
Zak Mir caught up with Howard White, Chairman of Hydrogen Utopia, to discuss th -
Zak Mir talks Ajax Resources with CEO Ippolito Cattaneo
Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources, in the wake of the h -
Zak Mir in conversation with Colin Bird on Kendrick’s Namibia rare earth deal
Zak Mir talks to Colin Bird, Executive Chairman, Kendrick Resources, as the min